Absorbed doses in the marrow during 131I therapy.
Absorbed doses in the marrow during 131I therapy.
复制标题
131I 治疗期间骨髓吸收的剂量。
DOI：
10.1259/0007-1285-50-593-329
复制
发表时间：
1977
期刊：
影响因子：
--
通讯作者：
A. Mcewan
中科院分区：
文献类型：
--
作者：
A. Mcewan
使用最近获得的数据重新评估了131 I治疗引起的红骨髓和血液吸收剂量。在计算中的Understanding进行了讨论，并与以前公布的剂量估计值进行了比较。甲状腺功能亢进症治疗的红骨髓平均剂量估计为0.59 rad mCi-1，而甲状腺功能正常状态为0.36 rad mCi-1。
Absorbed doses to red marrow and blood from 131I therapy have been re-evaluated using data which has become available more recently. Uncertainties in the calculations are discussed and a comparison is made with previously published dose estimates. The mean dose to red marrow from the treatment of hyperthyroidism is estimated to be 0.59 rad mCi-1, compared with 0.36 rad mCi-1 for the euthyroid state.